Table 3.
Comparison of our study with similar other studies
| Our study (2016) | Krishna et al.[7] (2015) | Gohel et al.[6] (2014) | Padmavathi et al.[22] (2013) | Anjaneyan et al.[18] (2013) | |
|---|---|---|---|---|---|
| Type of CADRS | 1. Rash | 1. Fixed drug eruptions | 1. Rash | 1. Fixed drug eruption | 1. Itching |
| 2. Itching or burning | 2. Acne | 2. Pruritus | 2. Maculopapular rash | 2. Rash | |
| 3. SJ syndrome | 3. Urticaria | 3. Urticaria | 3. Urticaria | 3. Swelling | |
| Causal drug groups | 1. Antimicrobials | Not done | 1. Antimicrobials | 1. Antimicrobials | 1.Antimicrobials |
| 2. NSAIDs | 2. NSAIDs | 2. NSAIDs | 2. NSAIDs | ||
| 3. Antiepileptic | 3. Not mentioned | 3. Unknown | 3. Antiepileptic | ||
| Causality | |||||
| 1. WHO-UMC | Not done | 21% | |||
| ‑Possible | 65.56% | 17.4% | 54.64% | 70% | |
| ‑ Probable | 32.99% | 52.4% | 36.08% | ||
| 2. Naranjo’s score | |||||
| ‑Possible | 54.61% | Not done | 21.65% | 22% | Not done |
| ‑Probable | 45.38% | 74.23% | 78% | ||
| Severity | |||||
| ‑Mild | 18.58% | 30.4% | 2% | 41.5% | Not done |
| ‑Moderate | 81.2% | 65.3% | 98% | 58.5% | |
| ‑Severe | 0.18% | 4.3% | 0 | 0 | |
| Preventability | |||||
| Definitely | – | 43.5% | 72.15% | 12.2% | Not done |
| Probably | 11.10% | 30.4% | 27.84% | – | |
| Not preventable | 88.90% | 26.1% | – | 87.8% |